Novartis AGNVSNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank86
5Y CAGR+8.2%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
+8.2%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202517.40%
202448.88%
202322.94%
2022-20.98%
2021-0.95%
202011.73%
20198.13%
2018-3.44%
20175.25%
2016-7.90%